← Leaderboards
Stanley M Lemon
Univ Of North Carolina Chapel Hill
$138,701,971
Attributed
$140,827,943
Total exposure
25
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $15.4M · FY2005–24$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$182,985,960 · 28
By mechanism
UC6$110,090,673 · 1
UC7$26,590,511 · 2
U19$15,130,422 · 4
R01$14,933,706 · 7
M01$10,618,614 · 1
C06$3,000,000 · 1
Top collaborators
- Lishan Su5 shared
- Jason Kyle Whitmire5 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Peyton J Thompson$1,004,363
- Joseph David Tucker$13,115,535
- Samantha Tulenko$179,695
- Camille Morgan$172,320
- You Li$213,813
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralCellsVirusProteinsComplexInfectionPlayHepatitis C VirusVirus ReplicationMediatingLiverVirionVirus DiseasesIn VitroHepatocyteProteomicsHepatitis CPathogenesisPathway InteractionsSignal TransductionHepatitis A VirusHepatitis AMembraneResponse
Grant awards (96)
Critical Lipid Species in the Hepatovirus Lifecycle$518,380
R01 · FY2024 · AI · contact PI
Critical Lipid Species in the Hepatovirus Lifecycle$516,845
R01 · FY2023 · AI · contact PI
Critical Lipid Species in the Hepatovirus Lifecycle$515,618
R01 · FY2022 · AI · contact PI
Critical Lipid Species in the Hepatovirus Lifecycle$514,390
R01 · FY2021 · AI · contact PI
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped Hepatovirus$388,750
R01 · FY2021 · AI · contact PI
Murine Model of Human Hepatitis A$388,750
R01 · FY2021 · AI · contact PI
Critical Lipid Species in the Hepatovirus Lifecycle$528,265
R01 · FY2020 · AI · contact PI
Murine Model of Human Hepatitis A$388,750
R01 · FY2020 · AI · contact PI
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped Hepatovirus$388,750
R01 · FY2020 · AI · contact PI
Micro-RNA 122 and Chronic Hepatitis C$380,000
R01 · FY2020 · AI · contact PI
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped Hepatovirus$521,332
R01 · FY2019 · AI · contact PI
Murine Model of Human Hepatitis A$388,750
R01 · FY2019 · AI · contact PI
Micro-RNA 122 and Chronic Hepatitis C$380,000
R01 · FY2019 · AI · contact PI
Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus$408,288
U19 · FY2018 · AI · contact PI
Murine Model of Human Hepatitis A$388,750
R01 · FY2018 · AI · contact PI
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped Hepatovirus$388,750
R01 · FY2018 · AI · contact PI
Micro-RNA 122 and Chronic Hepatitis C$380,000
R01 · FY2018 · AI · contact PI
Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus$407,732
U19 · FY2017 · AI · contact PI
Membrane Hijacking: Biogenesis and Fate of Quasi-Enveloped Hepatovirus$388,750
R01 · FY2017 · AI · contact PI
Murine Model of Human Hepatitis A$385,833
R01 · FY2017 · AI · contact PI
Micro-RNA 122 and Chronic Hepatitis C$380,000
R01 · FY2017 · AI · contact PI
Murine Model of HCV-Associated Human Liver Cancer$470,695
R01 · FY2016 · CA · contact PI
Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus$407,731
U19 · FY2016 · AI · contact PI
Micro-RNA 122 and Chronic Hepatitis C$380,000
R01 · FY2016 · AI · contact PI
Membrane Hijacking: Biogenesis and Fate of Enveloped Hepatovirus$380,000
R01 · FY2016 · AI · contact PI
Murine Model of HCV-Associated Human Liver Cancer$470,695
R01 · FY2015 · CA · contact PI
Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus$408,220
U19 · FY2015 · AI · contact PI
Membrane Hijacking: Biogenesis and Fate of Enveloped Hepatovirus$380,000
R01 · FY2015 · AI · contact PI
Micro-RNA 122 and Chronic Hepatitis C$368,389
R01 · FY2015 · AI · contact PI
Murine Model of HCV-Associated Human Liver Cancer$456,574
R01 · FY2014 · CA · contact PI
Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus$407,731
U19 · FY2014 · AI · contact PI
Membrane Hijacking: Biogenesis and Fate of Enveloped Hepatovirus$380,000
R01 · FY2014 · AI · contact PI
Micro-RNA 122 and Chronic Hepatitis C$368,389
R01 · FY2014 · AI · contact PI
Murine Model of HCV-Associated Human Liver Cancer$442,453
R01 · FY2013 · CA · contact PI
Membrane Hijacking: Biogenesis and Fate of Enveloped Hepatovirus$357,200
R01 · FY2013 · AI · contact PI
Micro-RNA 122 and Chronic Hepatitis C$346,286
R01 · FY2013 · AI · contact PI
Murine Model of HCV-Associated Human Liver Cancer$470,695
R01 · FY2012 · CA · contact PI
Membrane Hijacking: Biogenesis and Fate of Enveloped Hepatovirus$380,000
R01 · FY2012 · AI · contact PI
Micro-RNA 122 and Chronic Hepatitis C$368,389
R01 · FY2012 · AI · contact PI
Micro-RNA 122 and Chronic Hepatitis C$368,389
R01 · FY2011 · AI · contact PI
Hepatitis C and Tumor Suppressors in Hepatocellular$276,791
P20 · FY2011 · CA · contact PI
Administrative Services$2,142,864
UC7 · FY2010 · AI · contact PI
Hepatitis C and Tumor Suppressors in Hepatocellular$291,609
P20 · FY2010 · CA · contact PI
Intrahepatic IRF-3 and NF-kB Signaling and Interferon Responses in Hepatitis C$224,235
R21 · FY2010 · AI · contact PI
Administrative Services$2,142,864
UC7 · FY2009 · AI · contact PI
The Southeastern Cooperative Hepatitis C Research Group$1,454,533
U19 · FY2009 · AI · contact PI
Hepatitis C and Tumor Suppressors in Hepatocellular$298,854
P20 · FY2009 · CA · contact PI
Interferon Signaling and Cellular Permissiveness for Hepatitis C Virus (HCV)$205,197
U19 · FY2009 · AI · contact PI
Intrahepatic IRF-3 and NF-kB Signaling and Interferon Responses in Hepatitis C$188,750
R21 · FY2009 · AI · contact PI
Galveston National Laboratory Operations$12,000,000
UC7 · FY2008 · AI · contact PI
Administrative Services$1,714,290
UC7 · FY2008 · AI · contact PI
The Southeastern Cooperative Hepatitis C Research Group$1,414,039
U19 · FY2008 · AI · contact PI
Interferon Signaling and Cellular Permissiveness for Hepatitis C Virus (HCV)$199,186
U19 · FY2008 · AI · contact PI
Hepatic Inflammation and Immunity 2008$25,000
R13 · FY2008 · AI · contact PI
Galveston National Laboratory Operations$6,233,781
UC7 · FY2007 · AI · contact PI
The Southeastern Cooperative Hepatitis C Research Group$1,345,600
U19 · FY2007 · AI · contact PI
Administrative Services$605,516
UC7 · FY2007 · AI · contact PI
Interferon Signaling and Cellular Permissiveness for Hepatitis C Virus$203,944
U19 · FY2007 · AI · contact PI
SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$11,185
P51 · FY2007 · RR · contact PI
The Southeastern Cooperative Hepatitis C Research Group$1,355,272
U19 · FY2006 · AI · contact PI
Galveston National Laboratory Operations$1,285,873
UC7 · FY2006 · AI · contact PI
Administrative Services$465,323
UC7 · FY2006 · AI · contact PI
Interferon Signaling and Cellular Permissiveness for HCV$199,044
U19 · FY2006 · AI · contact PI
SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$45,755
P51 · FY2006 · RR · contact PI
CHIMERIC VIRUS PRIMATE MODEL OF HEPATITIS C$4,130
P51 · FY2006 · RR · contact PI
The Southeastern Cooperative Hepatitis C Research Group$1,367,930
U19 · FY2005 · AI
CHIMERIC VIRUS PRIMATE MODEL OF HEPATITIS C$270,902
R24 · FY2005 · RR
Interferon Signaling and Cellular Permissiveness for HCV$199,621
U19 · FY2005 · AI
Administrative Core$63,979
U19 · FY2005 · AI
SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$36,933
P51 · FY2005 · RR
CHIMERIC VIRUS PRIMATE MODEL OF HEPATITIS C$3,376
P51 · FY2005 · RR
GENERAL CLINICAL RESEARCH CENTER$1,614,246
M01 · FY2004 · RR
THE SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$1,051,648
U19 · FY2004 · AI
CHIMERIC VIRUS PRIMATE MODEL OF HEPATITIS C$271,691
R24 · FY2004 · RR
SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$55,275
P51 · FY2004 · RR
CHIMERIC VIRUS PRIMATE MODEL OF HEPATITIS C$5,516
P51 · FY2004 · RR
National Biocontainment Laboratory (NBL)$110,090,673
UC6 · FY2003 · AI
GENERAL CLINICAL RESEARCH CENTER$2,390,953
M01 · FY2003 · RR
THE SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$1,021,880
U19 · FY2003 · AI
CHIMERIC VIRUS PRIMATE MODEL OF HEPATITIS C$272,458
R24 · FY2003 · RR
SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$31,929
P51 · FY2003 · RR
CHIMERIC VIRUS PRIMATE MODEL OF HEPATITIS C$3,193
P51 · FY2003 · RR
GENERAL CLINICAL RESEARCH CENTER$2,383,063
M01 · FY2002 · RR
THE SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$996,802
U19 · FY2002 · AI
CHIMERIC VIRUS PRIMATE MODEL OF HEPATITIS C$285,452
R24 · FY2002 · RR
Hepatic Inflammation and Immunity 2002$19,000
R13 · FY2002 · AI
SELECTION OF CELL CULTURE-ADAPTED HEPATITIS C RNA$0
U19 · FY2002 · AI
GENERAL CLINICAL RESEARCH CENTER$2,164,701
M01 · FY2001 · RR
THE SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$963,535
U19 · FY2001 · AI
SELECTION OF CELL CULTURE-ADAPTED HEPATITIS C RNA$0
U19 · FY2001 · AI
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION$3,000,000
C06 · FY2000 · RR
GENERAL CLINICAL RESEARCH CENTER$2,065,651
M01 · FY2000 · RR
THE SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$1,048,510
U19 · FY2000 · AI
RHINOVIRUS REPLICONS AS VECTORS FOR MUCOSAL IMMUNIZATION$214,091
R01 · FY2000 · AI
STRUCTURE/FUNCTION RELATIONS IN HAV REPLICATION$200,798
R01 · FY2000 · AI
SELECTION OF CELL CULTURE-ADAPTED HEPATITIS C RNA$0
U19 · FY2000 · AI